The Therapeutic Effects of Adipose-Derived Stem Cells and Recombinant Peptide Pieces on Mouse Model of DSS Colitis
Cell therapies using adipose-derived stem cells (ADSCs) have been used to treat inflammatory bowel disease (IBD) in human and dog. We previously reported the CellSaic technique, which uses a recombinant scaffold to enhance the efficacy of cell therapy. To examine whether this technique can be applie...
Main Authors: | Reiko Iwazawa, Sayako Kozakai, Tsukasa Kitahashi, Kentaro Nakamura, Ken-ichiro Hata |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-09-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.1177/0963689718782442 |
Similar Items
-
The effects of DNase I treatment on mouse experimental DSS-induced colitis
by: Yi-Hsuan Hsu, et al.
Published: (2017) -
Effects of Naringein on the Dextran Sulfate Sodium (DSS) Colitis Mouse Model
by: Ma Thi Hoan, et al.
Published: (2015) -
The Effects of Bilirubin in the Dextran Sulfate Sodium (DSS) Mouse Colitis Model
by: Nong, Thi Phuong Nhung, et al.
Published: (2015) -
Time to Integrate to Nest Test Evaluation in a Mouse DSS-Colitis Model.
by: Christine Häger, et al.
Published: (2015-01-01) -
Recombinant antimicrobial peptide microcin J25 alleviates DSS-induced colitis via regulating intestinal barrier function and modifying gut microbiota
by: Lijun Shang, et al.
Published: (2021-07-01)